Oral Arsenic With ATRA for Newly Diagnosed Patients With Acute Promyelocytic Leukemia

NCT06982274 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
115
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Instituto do Cancer do Estado de São Paulo

Collaborators